Skip to main content
Premium Trial:

Request an Annual Quote

Kinematik Joins Microsoft's BioIT Alliance

NEW YORK (GenomeWeb News) – Kinematic will team with Microsoft and several other life sciences and software companies and organizations by joining the BioIT Alliance, the company said Monday.

The alliance, started by Microsoft in 2006, aims to develop software and information management tools that can help speed the advance of drug development and personalized medicine.
 
San Diego-based Kinematic provides a software system called eNovator that life sciences companies can use to help capture, manage, and reuse data and information.  

The system includes an electronic lab notebook and systems designed for knowledge management, project management, clinical trials, and quality and training purposes.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.